Miquel H. Vila

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

The Vall d'Hebron Initiative for Parkinson (VHIP) cohort: a prospective, longitudinal, and observational study enrolling de novo Parkinson's disease patients for biomarker identification and validation.

The Vall d'Hebron Initiative for Parkinson (VHIP) cohort: a prospective, longitudinal, and observational study enrolling de novo Parkinson's disease patients for biomarker identification and validation.

Journal: Frontiers in aging neuroscience

Published: April 17, 2026

Response to: Neuromelanin? T 1 shortening is a necessary condition.

Response to: Neuromelanin? T 1 shortening is a necessary condition.

Journal: Brain communications

Published: February 23, 2026

Divergent tau pathology profiles induced by distinct alpha-synuclein aggregates in non-human primates.

Divergent tau pathology profiles induced by distinct alpha-synuclein aggregates in non-human primates.

Journal: Brain : a journal of neurology

Published: January 13, 2026

Effects of neuromelanin buildup in rodent nigral dopamine neurons: implications for sex-biased vulnerability in Parkinson's disease.

Effects of neuromelanin buildup in rodent nigral dopamine neurons: implications for sex-biased vulnerability in Parkinson's disease.

Journal: Neurobiology of disease

Published: December 17, 2025

Introducing PIGMO, a novel PIGmented MOuse model of Parkinson's disease.

Introducing PIGMO, a novel PIGmented MOuse model of Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: September 22, 2025

Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations.

Cell-based regenerative interventions in Parkinson's disease: Overcoming pharmacological limitations.

Journal: Acta pharmaceutica Sinica. B

Published: August 19, 2025

Phenotypic characterization of an Atp13a2 knockout rat model of Parkinson's disease.

Phenotypic characterization of an Atp13a2 knockout rat model of Parkinson's disease.

Journal: NPJ Parkinson's disease

Published: July 11, 2025

Differential pathological dynamics triggered by distinct Parkinson patient-derived α-synuclein extracts in nonhuman primates.

Differential pathological dynamics triggered by distinct Parkinson patient-derived α-synuclein extracts in nonhuman primates.

Journal: Science advances

Published: June 18, 2025

Single-cell transcriptomics for immune profiling of cerebrospinal fluid in neurological diseases.

Single-cell transcriptomics for immune profiling of cerebrospinal fluid in neurological diseases.

Journal: Frontiers in immunology

Published: March 24, 2025

Standardised TruAI Automated Quantification of Intracellular Neuromelanin Granules in Human Brain Tissue Sections.

Standardised TruAI Automated Quantification of Intracellular Neuromelanin Granules in Human Brain Tissue Sections.

Journal: Neuropathology and applied neurobiology

Published: January 22, 2025

Neuromelanin and selective neuronal vulnerability to Parkinson's disease.

Neuromelanin and selective neuronal vulnerability to Parkinson's disease.

Journal: Trends in neurosciences

Published: January 10, 2025

LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model.

LRRK2-mutant microglia and neuromelanin synergize to drive dopaminergic neurodegeneration in an iPSC-based Parkinson's disease model.

Journal: Communications biology

Published: December 19, 2024

Showing 1-12 of 93

Last Updated: 09/26/2026